Individual results vary significantly, and factors like starting weight, diet, exercise, and genetics all influence outcomes
However, this medication isn't recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Nearly 1B people will be clinically obese by 2032 and only one solution works for them (GLP-1) Fede Buldin (Co-founder) - Former AI Founder at Bookline.ai, AI Analyst at Accenture
All GLP-1 receptor agonists cause similar modest heart rate increases of approximately 24 beats per minute on average, including liraglutide, semaglutide, dulaglutide, and tirzepatide
Nishida Y, MD, PhD, Ishizawa J, MD, PhD, Ayoub E, PhD, Patsilevas T, BS, Ostermann L, Montoya RH, BS, Muftuoglu M, MD, Ruvolo V, MS, Mak PY, Tao W, Carter BZ, PhD, Kojima K, MD, PhD, Daver N, MD, Lesegretain A, Seki T, PhD, Shacham S, PhD, MBA, Konopleva M, MD, PhD, Andreeff M , MD, PhD
The safest approach is to consider two questions: Am I eating and drinking normally
